US FDA points out manufacturing lapses at Lupin's Tarapur API plant

US Food and Drug Administration (US FDA) has pointed out various manufacturing lapses at drug maker Lupin's Tarapur plant in Thane, which produces active pharmaceutical ingredients (API). In a warning letter, FDA said the plant failed to establish adequate written procedures for cleaning equipment. The health regulator inspected the plant from March 22 to April 4, 2022.